Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Accepts healthy volunteers Results available

Safety and Immunogenicity of Flublok Quadrivalent vs IIV4 in Adults 18-49 Years of Age

ClinicalTrials.gov ID: NCT02290509

Public ClinicalTrials.gov record NCT02290509. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 1:28 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Double-Blind, Randomized, Active-Controlled Comparison of the Immunogenicity and Safety of Flublok® Quadrivalent Versus IIV4 in Healthy, Medically Stable Adults 18-49 Years of Age

Study identification

NCT ID
NCT02290509
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Protein Sciences Corporation
Industry
Enrollment
1,350 participants

Conditions and interventions

Conditions

Interventions

  • Flublok Quadrivalent Biological
  • Inactivated Influenza Vaccine (IIV4) Biological

Biological

Eligibility (public fields only)

Age range
18 Years to 49 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2014
Primary completion
Apr 30, 2015
Completion
Apr 30, 2015
Last update posted
Oct 26, 2016

2014 – 2015

United States locations

U.S. sites
10
U.S. states
8
U.S. cities
10
Facility City State ZIP Site status
Benchmark Research - Sacramento Sacramento California 95816
Clinical Research of South Florida Coral Gables Florida 33134
Meridian Clinical Research Savannah Georgia 31406
Heartland Research Associates, LLC Wichita Kansas 67207
Benchmark Research Metairie Louisiana 70006
Meridian Research Bellevue Nebraska 68005
Meridian Clinical Research Omaha Nebraska 68164
Meridian Research Dakota Dunes South Dakota 57049
Benchmark Reseach Austin Texas 78705
Benchmark Research - Fort Worth Fort Worth Texas 76135

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02290509, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 26, 2016 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02290509 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →